With exports booming and incentives flowing, India’s electronics and pharma sectors emerge as the biggest winners of the PLI scheme in a manufacturing-led growth story.
India’s electronics sector emerged as the top gainer under the government’s Production-Linked Incentive (PLI) scheme in FY2024-25, followed by the pharmaceutical sector, receiving nearly 70% of the total incentives disbursed.
According to official data cited in a PTI report, out of ₹101.14 billion released under the scheme, electronics firms received ₹57.32 billion, while pharmaceutical companies secured ₹23.28 billion. This marks an approximately 4.04% rise from ₹97.21 billion disbursed in FY24.
Launched in 2021, the PLI scheme was aimed at enhancing domestic manufacturing across 14 key sectors. With increasing uptake and results, the scheme is now seen as a cornerstone of India’s industrial strategy.
Electronics manufacturing, in particular, has seen remarkable progress. The sector now reportedly ranks among India’s top three export categories. In FY25, electronic goods exports rose 32.5% year-on-year (YoY), climbing from US$29.12 billion to US$38.58 billion. This builds on growth from US$23.6 billion in FY23 and US$15.7 billion in FY22.
One standout performer was the computer hardware and peripherals segment, which more than doubled its exports. Shipments rose 101% from USD 0.7 billion to USD 1.4 billion. Major export destinations included the UAE, US, UK, the Netherlands, and Italy.
The pharmaceutical industry also continued its steady global expansion. Drug exports rose nearly 10% in FY25, reaching US$30.5 billion. Indian pharmaceuticals are now being shipped to over 200 countries.
With rising interest from global firms and steady policy support, both electronics and pharma are expected to boost India’s push to become a manufacturing hub.
Government officials view the PLI scheme as a key driver in expanding high-value exports and reducing import dependency.
